Lercanidipine-induced chylous ascites: Case report and literature review

被引:5
作者
Basualdo, J. E. [1 ]
Rosado, I. A. [1 ]
Morales, M. I. [2 ]
Fernandez-Ros, N. [1 ]
Huerta, A. [1 ]
Alegre, F. [1 ]
Landecho, M. F. [1 ]
Lucena, J. F. [1 ]
机构
[1] Clin Univ Navarra, Div Intermediate Care & Hosp Unit, Dept Internal Med, Pamplona, Spain
[2] Clin Univ Navarra, Dept Nucl Med, Pamplona, Spain
关键词
adverse drug reaction; calcium channel blockers; chylous ascites; lercanidipine; INDUCED CHYLOPERITONEUM; PATIENT;
D O I
10.1111/jcpt.12555
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
What is known and objectiveChylous ascites is a rare condition. The most frequent causes are lymphomas, solid malignancies, abdominal trauma and cirrhosis. Isolated case reports describe the relationship between calcium channel blockers (CCB) and chyloperitoneum. Lercanidipine is a third-generation dihydropyridine with low rate of adverse events. We describe a case of lercanidipine-induced chylous ascites. Case summaryAn 80-year-old white female with hypertension treated with lercanidipine, developed chylous ascites and abdominal pain after the dosage of the CCB was doubled. The initial suspicion was a hidden neoplasm, but after a thorough research, no apparent cause was detected and the symptoms resolved after the drug was suspended. What is new and conclusionCalcium channel blockers should be considered as possible causes in cases of chyloperitoneum of unknown aetiology.
引用
收藏
页码:638 / 641
页数:4
相关论文
共 14 条
[1]   Chylous ascites: A collective review [J].
Aalami, OO ;
Allen, DB ;
Organ, CH .
SURGERY, 2000, 128 (05) :761-778
[2]  
Betancourt L, 2003, NEFROLOGIA, V33, P377
[3]  
Cárdenas A, 2002, AM J GASTROENTEROL, V97, P1896
[4]  
Epstein M, 2001, Heart Dis, V3, P398
[5]   Fat chance that the patient becomes the doctor! [J].
Granel, B ;
Rossi, P ;
Bagneres, D ;
Demoux, AL ;
Aissi, K ;
Bonin-Guillaume, S ;
Frances, Y .
REVUE DE MEDECINE INTERNE, 2005, 26 :S206-S207
[6]   Distinct roles of L- and T-type voltage-dependent Ca2+ channels in regulation of lymphatic vessel contractile activity [J].
Lee, Stewart ;
Roizes, Simon ;
von der Weid, Pierre-Yves .
JOURNAL OF PHYSIOLOGY-LONDON, 2014, 592 (24) :5409-5427
[7]   NON-INFECTIOUS CLOUDY PERITONEAL FLUID SECONDARY TO LERCANIDIPINE [J].
Moreiras-Plaza, Mercedes ;
Fernandez-Fleming, Francisco ;
Martin-Baez, Isabel ;
Blanco-Garcia, Raquel ;
Beato-Coo, Laura .
NEFROLOGIA, 2014, 34 (05) :683-685
[8]   EVALUATION AND MANAGEMENT OF CHYLOUS ASCITES [J].
PRESS, OW ;
PRESS, NO ;
KAUFMAN, SD .
ANNALS OF INTERNAL MEDICINE, 1982, 96 (03) :358-364
[9]   Aliskiren-Induced Chyloperitoneum in a Patient on Peritoneal Dialysis [J].
Saka, Y. ;
Tachi, H. ;
Sakurai, H. ;
Tawada, M. ;
Sawai, A. ;
Shimamura, Y. ;
Mizuno, M. ;
Maruyama, S. ;
Matsuo, S. ;
Ito, Y. .
PERITONEAL DIALYSIS INTERNATIONAL, 2012, 32 (01) :111-U123
[10]  
Tanabe M, 1999, CLIN NEPHROL, V51, P195